top of page

SEPTEMBER 19

A detailed program is provided below. You may also access specific session details by selecting your desired session within the respective hall.

Day 3. September 19th.

Tate Modern

09:00 - 10:30 Session I - Miscellaneous.

Chairs: M. Menegolo; L. Palombo

  • T. Balezantis  —  Thoracic outlet syndrome: results of surgical treatment from a single centre in Denmark

  • G. F. Torsello  —  To be confirmed

  • R. Gircius  —  Vascular erectile dysfunction: an IR approach to diagnosis and endovascular treatment

  • Y. Nahaliuk  —  Challenges in management and outcome tracking of major extremity vascular injuries during armed conflict: experience from 900 military patients

  • T. Kobza  —  Thoracic vascular injuries in modern war

  • I. Nesterenko  —  War-driven evolution of infectious complications in vascular surgery

  • C. Zeebregts  —  Vascular graft and endograft infection: what have we learned since the ESVS guidelines?

  • M. Sallam  —  Lessons learned from 100 aortic graft infections

11:00 - 12:30 Session II - Science and Innovations.

Chairs: L. Patrone; A. Ysa

  • P. Sotonyi  —  Vessel wall inflammation – the role of the vascular wall, thrombus, blood, and gut microbiome in abdominal aortic aneurysm development

  • I. Koncar  —  Tropicar

  • D. Krievins  —  FFR + CEA

  • J. Ferreira  —  Distinct cytokine signatures in chronic limb-threatening ischemia: a prospective longitudinal study

  • M. Lichtenberg  —  New stent

  • P. Sotonyi  —  Digital variance angiography: a new way to improve vascular imaging in the operating room

  • I. Koncar  —  Establishing a national registry – experience from SerbVasc

Day 3. September 19th.

MoMA

09:00 - 10:30 Session I - Venous I.

Chairs: To be confirmed

  • S. Urbonavicius  —  New insights into an old problem: proteomic evidence for extracellular matrix degradation in varicose vein pathogenesis

  • J. Ferreira  —  Chronic venous disease and sleep disorders

  • M. Wikeling  —  To be confirmed

  • M. G. Stanisic  —  Iliac vein stenting: how to do it right and who should not be stented

  • M. Lichtenberg  —  New developments in mechanical thrombectomy for iliofemoral DVT

  • M. Jaworski  —  Open thrombectomy in acute iliofemoral venous thrombosis – is it still a valid option?

  • V. Palmiste  —  Pelvic varicosities: to treat or not to treat? 10+ years of Estonian experience and conclusions from that

11:00 - 12:30 Session II - Venous II.

Chairs: To be confirmed

  • T. Urbanek  —  Delayed intervention for superficial vein varicose vein C2–3 disease reflects good medical practice

  • U. Maurins  —  Early intervention for superficial vein varicose vein C2–3 disease reflects good medical practice

  • E. Roche  —  Foam sclerotherapy: contemporary and future applications

  • I. Udris  —  TOTAL EVLA: five-year long-term clinical outcomes

  • F. Žernovicky  —  The great saphenous vein: treat it or save it? Balancing venous disease and future arterial revascularization

  • L. Palombi  —  Laser fibers for endovenous laser ablation: does size matter?

  • J. Szczepanski  —  Virtual reality in office-based venous procedures: early experience and practical considerations

Day 3. September 19th.

d'Orsay

09:00 - 10:30 Session I - Rapid fire Cardiac I. 

Chairs: To be confirmed

Programme to be confirmed.

11:00 - 12:30 Session II - Rapid fire Cardiac II. 

Chairs: To be confirmed

Programme to be confirmed.

bottom of page